Brendan A Harley

Title: Brendan A Harley: Innovator in Biomaterials

Introduction

Brendan A Harley is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomaterials, particularly in the development of scaffolds for tissue regeneration. With a total of 2 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

One of Harley's latest patents is titled "Scaffold comprising co-precipitated Collagen and glycosaminoglycan for inhibiting adhesion of body tissue layers." This invention involves a device designed to inhibit the adhesion of apposing human body tissue layers. The scaffold is strategically positioned between tissue layers at a wound site, allowing for remesothelialization without the formation of fibrous adhesions. The device promotes contractile cell migration away from the wound site for a predetermined period, thereby enhancing tissue regeneration and the delivery of therapeutic agents in vivo.

Another significant patent by Harley is related to a "Biomaterial," which outlines a process for preparing a composite biomaterial. This process includes providing a solid component with a porous surface and a fluid composition that transforms into solid crystals or particles upon cooling. The innovative approach aims to enhance the properties of biomaterials used in medical applications.

Career Highlights

Throughout his career, Brendan A Harley has worked with various organizations, including Axle International Ltd. and Cambridge Enterprise Limited. His experience in these companies has contributed to his expertise in biomaterials and tissue engineering.

Collaborations

Harley has collaborated with notable individuals in his field, including Eric C Soller and Eric Aiazian. These collaborations have further enriched his research and development efforts in biomaterials.

Conclusion

Brendan A Harley is a distinguished inventor whose work in biomaterials has the potential to significantly impact medical science. His innovative patents and career achievements reflect his dedication to advancing tissue regeneration technologies.